At the IGTP TODAY

News

- Campus Can Ruti, Research

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

The study, published in Nature Communications, evaluates ibuprofen for the first time in patients with tuberculosis as an adjunctive therapy aimed at modulating the host inflammatory response. The results did not show an improvement in the main clinical or microbiological outcomes, but they did reveal biological changes consistent with reduced inflammation, supporting further investigation of this approach in larger, controlled trials.

- Campus Can Ruti, Research

Screening high-risk groups for tuberculosis in low-incidence countries: a cost-effective strategy

A study led by researchers from IGTP, in collaboration with health economics experts from Can Ruti, UPF, and Agència de Salut Pública de Barcelona, offers new recommendations for optimising tuberculosis screening programmes in low-incidence countries. Published in the journal Eurosurveillance, this work reviews various studies to determine if these programmes targeting higher-risk groups are economically effective.